Lynk Pharmaceuticals Announced First Rheumatoid Arthritis Patient Dosed in Phase Ⅲ Clinical Study of LNK01001
Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as ‘Lynk Pharmaceuticals’), an innovative clinical stage company, announced that it has dosed the first patient with Rheumatoid Arthritis (RA) in a Phase Ⅲ clinical trial of its highly selective JAK1 inhibitor LNK01001….
Aster Medcity, Kochi attains milestone with first-ever Sacral Nerve Neuromodulation Surgery in Kerala.
In a first-of-its-kind surgery in Kerala, Aster Medcity, a leading integrated healthcare organization under Aster DM healthcare, has pushed the frontiers of medicine by using Sacral Neuromodulation Surgery to treat overactive bladder syndrome. The overactive bladder, characterized by the frequent…
